Zheying Mao

Introduction Since the outbreak of COVID-19 in early 2020, more than 7.1 million deaths have been reported globally.1 Although existing studies indicate a declining trend in the severe case rate of SARS-CoV-2 infection, recent evidence indicates that emerging viral variants exhibit enhanced affinity for human upper respiratory tract tissues, which significantly increases their transmission efficiency.2 Consequently, the virus continues to pose an ongoing threat to global public health.

Back to Journals » Infection and Drug Resistance » Volume 19 Authors Li Y, Huang M, Mao Z, Liu C, Qu W, Ni J, Xu W, Li A, Bao J, Han D, Yu F, Shen Y, Wang Y , Chen W, Zheng S Received 18 December 2025 Accepted for publication 6 April 2026 Published 8 June 2026 Volume 2026:19 586598 DOI https://doi.org/10.2147/IDR.S586598 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Oliver Planz Yuxia Li,1,* Mingzhu...